SOLV · 10-Q · 2026Q2 · Full report

Geographic Revenue Commentary

Solventum Corp · 2026-08-05 · Importance 54 · Surprise 40 · No source text

United States sales were $1.313 billion in the second quarter of 2026, representing 59.4% of worldwide sales, and increased 10.4% on a reported basis. International sales represented 40.6% of worldwide sales and declined 7.8% on a reported basis, despite 4.1% organic growth, because divestiture effects reduced sales by 14.2%. For the first six months, United States sales were $2.474 billion, or 58.7% of worldwide sales, and increased 6.2%, while international sales were $1.741 billion and declined 8.4%. U.S. growth was led by MedSurg and Dental Solutions and benefited from advanced ERP-related customer ordering, whereas international organic growth was led by Dental Solutions and MedSurg.

Key facts

• United States net sales for the three months ended June 30, 2026 were $1,313 million, representing 59.4% of worldwide sales for the quarter. source
• International net sales for the three months ended June 30, 2026 represented 40.6% of worldwide sales and worldwide net sales totaled $2,209 million. source
• For the six months ended June 30, 2026, United States net sales were $2,474 million and International net sales were $1,741 million, totaling $4,216 million worldwide, with the U.S. representing 58.7% of worldwide sales. source
• Sales in the United States geographic area experienced organic growth of 13.5% for the three months ended June 30, 2026 and 9.0% for the six months ended June 30, 2026. source
• The increase in the effective tax rate for the three months ended June 30, 2026 is primarily attributable to an unfavorable geographic mix of earnings. source

Impact estimates